insulin degludec 100 UNT/ML Injectable Solution [Tresiba]
- RxCUI
- 2107522
- RxNorm name
- insulin degludec 100 UNT/ML Injectable Solution [Tresiba]
- Display name
- insulin degludec 100 UNT/ML Injectable Solution [Tresiba]
- Full name
- insulin degludec 100 UNT/ML Injectable Solution [Tresiba]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 203314 | Tresiba | insulin degludec | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tresiba | INSULIN DEGLUDEC | Novo Nordisk | 456c5e87-3dfd-46fa-8ac0-c6128d4c97c6 | 2022-07-01 | Warnings, Adverse reactions | 2107522 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 456c5e87-3dfd-46fa-8ac0-c6128d4c97c6 | Tresiba 100 UNT/mL Injectable Solution [PSN] · insulin degludec 100 UNT/ML Injectable Solution [Tresiba] [SBD] · Tresiba 100 UNT/ML Injectable Solution [SY] | 3 | 14 | These highlights do not include all the information needed to use TRESIBA safely and effectively. See full prescribing information for TRESIBA. TRESIBA ® (insulin degludec) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20220701 |